IGF1 and neoplasm: Fasting sensitizes low immunogenic non-small-cell lung cancer lung tumors to anti-PD1 immunotherapy and even leads to complete tumor remission in preclinical studies by reversing or neutralizing the immune evasion mechanism through IGF-I signaling pathway downregulation [271].